0000905718-18-000283.txt : 20180228 0000905718-18-000283.hdr.sgml : 20180228 20180228140452 ACCESSION NUMBER: 0000905718-18-000283 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180228 DATE AS OF CHANGE: 20180228 EFFECTIVENESS DATE: 20180228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-298948 FILM NUMBER: 18649968 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 D/A 1 primary_doc.xml X0708 D/A LIVE 0001175680 CytoDyn Inc. 1111 MAIN STREET, SUITE 660 VANCOUVER WA WASHINGTON 98660 360-980-8524 DELAWARE RexRay Corporation CYTODYN INC REXRAY CORP Corporation true Nader Z. Pourhassan 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Director Michael D. Mulholland 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Jordan G. Naydenov 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Anthony D. Caracciolo 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Director Gregory A. Gould 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Alan Bruce Montgomery 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Carl C. Dockery 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Denis R. Burger 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Scott A. Kelly 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Biotechnology Decline to Disclose 06b true 0000905718-17-000980 2017-11-02 false true true true false 0 Paulson Investment Company, LLC 5670 None None 2141 W. NORTH AVE. 2ND FLOOR CHICAGO IL ILLINOIS 60647 All States false 17643452 17643452 0 false 200 1714000 true 0 Excludes value of warrants to purchase up to 2,813,490 shares of common stock. 0 true Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3. false CytoDyn Inc. /s/ Michael D. Mulholland Michael D. Mulholland Chief Financial Officer 2018-02-28